SC 13G/A: Milestone Pharmaceuticals Inc.

AI Summary

SC 13G/A filing by Milestone Pharmaceuticals Inc..

Risk Assessment

Risk Level: low

Filing Documents

• tm246235d17_sc13ga.htm (SC 13G/A) — 145KB
• 0001104659-24-024237.txt ( ) — 147KB

From the Filing

SC 13G/A 1 tm246235d17_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Milestone Pharmaceuticals Inc. (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 59935V107 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 59935V107 Page 2 of 13 1. Name of reporting persons Venrock Healthcare Capital Partners III, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) 1 (b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 925,048 2 7. Sole Dispositive Power 0 8. Shared Dispositive Power 925,048 2 9. Aggregate Amount Beneficially Owned by Each Reporting Person 925,048 2 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 2.8% 3 12. Type of Reporting Person (See Instructions) PN 1 Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A. 2 Consists of (i) 243,195 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 24,330 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 657,523 shares held by Venrock Healthcare Capital Partners EG, L.P. 3 This percentage is calculated based upon 33,483,111 of the Issuer’s common shares outstanding as of November 13, 2023 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2023. CUSIP No. 59935V107 Page 3 of 13 1. Name of reporting persons VHCP Co-Investment Holdings III, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) 1 (b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 925,048 2 7. Sole Dispositive Power 0 8. Shared Dispositive Power 925,048 2 9. Aggregate Amount Beneficially Owned by Each Reporting Person 925,048 2 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 2.8% 3 12. Type of Reporting Person (See Instructions) OO 1 Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A. 2 Consists of (i) 243,195 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 24,330 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 657,523 shares held by Venrock Healthcare Capital Partners EG, L.P. 3 This percentage is calculated based upon 33,483,111 of the Issuer’s common shares outstanding as of November 13, 2023 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2023. CUSIP No. 59935V107 Page 4 of 13 1. Name of reporting persons Venrock Healthcare Capital Partners EG, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) 1 (b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 925,048 2 7. Sole Dispositive Power 0 8. Shared Dispositive Power 925,048 2 9. Aggregate Amount Beneficially Owned by Each Reporting Person 925,048 2 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 2.8% 3 12. Type of Reporting Person (S

View Full Filing

View this SC 13G/A filing on SEC EDGAR